Social stress is a risk factor for psychiatric disorders, however only a subset of the population is susceptible while others remain resilient. Inflammation has been linked to the pathogenesis of psychosocial disorders in humans and may underlie these individual differences. Using a resident-intruder paradigm capable of revealing individual differences in coping behavior and inflammatory responses, the present study determined if resveratrol (RSV; 0, 10, 30 mg/kg/day) protected against persistent stress-induced inflammation in socially defeated rats. Furthermore, the antidepressant efficacy of RSV was evaluated using the sucrose preference test. Active coping rats were characterized by more time spent in upright postures and increased defeat latencies versus passive coping rats. Five days after defeat, flow cytometry revealed enhanced stimulation of proinflammatory proteins (IL-b, TNF-a) in spleen cells of passive rats as compared to active coping and controls, an effect that was blocked by both doses of RSV. Furthermore, only passive coping rats exhibited increased proinflammatory proteins (IL-1b, TNF-a, GM-CSF) in the locus coeruleus (LC), a noradrenergic brain region implicated in depression. Notably, only 30 mg/kg RSV blocked LC neuroinflammation and importantly, was the only dose that blocked anhedonia. Alternatively, while stress had minimal impact on resting cytokines in the dorsal raphe (DR), RSV dose-dependently reduced DR cytokine expression. However, this did not result in changes in indoleamine 2,3-dioxygenase activity or serotonin levels. Taken together, these data suggest that social stress-induced depressive-like behavior evident in passive coping rats may be driven by stress-induced neuroinflammation and highlight natural anti-inflammatory agents to protect against social stress-related consequences.
a b s t r a c t
Social stress is a risk factor for psychiatric disorders, however only a subset of the population is susceptible while others remain resilient. Inflammation has been linked to the pathogenesis of psychosocial disorders in humans and may underlie these individual differences. Using a resident-intruder paradigm capable of revealing individual differences in coping behavior and inflammatory responses, the present study determined if resveratrol (RSV; 0, 10, 30 mg/kg/day) protected against persistent stress-induced inflammation in socially defeated rats. Furthermore, the antidepressant efficacy of RSV was evaluated using the sucrose preference test. Active coping rats were characterized by more time spent in upright postures and increased defeat latencies versus passive coping rats. Five days after defeat, flow cytometry revealed enhanced stimulation of proinflammatory proteins (IL-b, TNF-a) in spleen cells of passive rats as compared to active coping and controls, an effect that was blocked by both doses of RSV. Furthermore, only passive coping rats exhibited increased proinflammatory proteins (IL-1b, TNF-a, GM-CSF) in the locus coeruleus (LC), a noradrenergic brain region implicated in depression. Notably, only 30 mg/kg RSV blocked LC neuroinflammation and importantly, was the only dose that blocked anhedonia. Alternatively, while stress had minimal impact on resting cytokines in the dorsal raphe (DR), RSV dose-dependently reduced DR cytokine expression. However, this did not result in changes in indoleamine 2,3-dioxygenase activity or serotonin levels. Taken together, these data suggest that social stress-induced depressive-like behavior evident in passive coping rats may be driven by stress-induced neuroinflammation and highlight natural anti-inflammatory agents to protect against social stress-related consequences.
Ó 2016 Elsevier Inc. All rights reserved.
Introduction
It has long been recognized that repeated exposure to social stress can result in the development of depression (Almeida, 2005) . Affecting approximately 7 percent of adults and 11 percent of adolescents, depression is considered to be one of the most common debilitating diseases in the United States (National institute of mental health 2013a,b), yet there is significant individual variability in susceptibility, which has been attributed to differences in coping style (Veenema et al., 2003) . In humans, passive coping, such as avoidance or substance abuse, is associated with increased stress susceptibility, while active coping, such as problem solving, is associated with stress resiliency (Cairns et al., 2014) . This phenomenon has also been observed in rodents where passive coping results in the development of physiological and behavioral endpoints comparable to a depressive-like state, which is not evident in animals which adopt active coping strategies (Ahmed et al., 2014; De Miguel et al., 2011; Gomez-Lazaro et al., 2011; Korte et al., 1992; Perez-Tejada et al., 2013; Wood et al., 2010; Wood et al., 2015 Wood et al., , 2013 .
Interestingly, coping in both humans and rodents has been shown to play a large role in inflammatory responses to an immune challenge. For example, lipopolysaccharide stimulation of cytokine release in whole plasma is greater in passive versus active coping individuals (Bouhuys et al., 2004) . Furthermore, unstimulated resting levels of peripheral cytokines, such as interleukin (IL)-6 and tumor necrosis factor (TNF)-a are increased in subpopulations of depressed patients (Alesci et al., 2005; Bouhuys et al., 2004; Maes et al., 1997; Miller et al., 2002; Motivala et al., 2005; Musselman et al., 2001; Raison et al., 2013 
